Skip to content
lifestyle.ebusinessplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vanta Holdings Inc.
Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
August 21, 2026
Vanta Commends U.S. FDA Advisory Committee Vote Recommending Inclusion of Six Peptide Substances on FDA’s 503A Bulks List, Including BPC-157, TB-500 and MOTS-c
July 28, 2026
Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million
May 6, 2026
Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
May 5, 2026
Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
March 26, 2026
Vanta Announces U.S. Ticker Symbol Change to VNTXF
March 26, 2026